Maldives launches first public DNA lab for thalassemia testing
Government facility will expand genetic screening for inherited blood disorders, reducing reliance on overseas testing and improving early diagnosis
MALE, Maldives (MNTV) — The Maldives has opened its first government-run molecular DNA laboratory for thalassemia testing, marking a significant step in strengthening the country’s ability to diagnose inherited blood disorders without relying on laboratories overseas.
The new facility, launched at the Maldivian Blood Services, will conduct advanced DNA tests for thalassemia and other hemoglobin-related disorders. Health Minister Abdulla Nazim inaugurated the laboratory, which was established with an investment of 2.5 million Maldivian rufiyaa ($162,000) from the state budget.
Until now, comprehensive molecular testing for many hereditary blood mutations was available only through a private provider, limiting access and increasing costs for many patients.
Hospital officials said the new laboratory can identify 27 different genetic mutations linked to thalassemia and other inherited blood conditions. The facility is also equipped with testing kits developed using genetic standards specific to the Maldivian population, allowing more accurate diagnosis of diseases commonly seen in the country.
Speaking at the inauguration, Ibrahim Abdul Razzaq Haleem, chief executive officer of the Malé City Group of Hospitals, said the laboratory would detect several clinically important mutations that could not be identified through previous testing methods.
He said earlier identification of thalassemia carriers, particularly before marriage and at a young age, would strengthen national efforts to reduce the incidence of the inherited disorder.
Authorities also said the government is working to introduce prenatal diagnostic services, which would further improve early detection and genetic counseling.
Thalassemia is an inherited blood disorder that reduces the body’s ability to produce healthy hemoglobin, often requiring lifelong blood transfusions and specialized medical care.
Carrier screening and genetic testing are widely regarded as key public health tools for reducing the number of children born with severe forms of the disease.
The Maldives has one of the world’s highest rates of thalassemia carriers relative to its population, making early diagnosis and genetic screening an important component of the country’s healthcare strategy.
Officials said the new laboratory is expected to improve access to specialized testing while reducing waiting times and dependence on foreign diagnostic services.
We must take charge of our narrative. Research indicates that 92% of their Muslim coverage is negative. Help us change that.
Have Your Say!
Have you been affected by the issues raised in this story? Please share your experiences by emailing haveyoursay@soundvision.com.
Please include a contact number if you are willing to speak to a Muslim Network TV’s representative. You can also get in touch in the following ways:
Tweet: @MuslimNetworkTV
